| scholarly article | Q13442814 |
| P50 | author | Joachim H. Ix | Q87220141 |
| Michael G Shlipak | Q87224063 | ||
| Ian H de Boer | Q88112320 | ||
| Ruth F Dubin | Q90584372 | ||
| P2093 | author name string | Carmen A. Peralta | |
| Joachim Ix | |||
| Michael Shlipak | |||
| Yongmei Li | |||
| Nancy Jenny | |||
| Ruth Dubin | |||
| P2860 | cites work | Excess risk of chronic kidney disease among African-American versus white subjects in the United States: a population-based study of potential explanatory factors | Q74644319 |
| Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988-1994 and 1999-2004 | Q82285327 | ||
| Journal of Nephrology | Q15765408 | ||
| Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study | Q24646339 | ||
| Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD | Q24652643 | ||
| Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: results of a 4-year follow-up study | Q24654287 | ||
| The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE> | Q28204197 | ||
| Cystatin C and the risk of death and cardiovascular events among elderly persons | Q28251528 | ||
| Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease | Q28257707 | ||
| Multi-Ethnic Study of Atherosclerosis: objectives and design | Q29615490 | ||
| Association of kidney function with inflammatory and procoagulant markers in a diverse cohort: a cross-sectional analysis from the Multi-Ethnic Study of Atherosclerosis (MESA). | Q33357921 | ||
| Structural and functional vascular alterations and incident hypertension in normotensive adults: the Multi-Ethnic Study of Atherosclerosis | Q33566795 | ||
| An integrated view of humoral innate immunity: pentraxins as a paradigm | Q34020449 | ||
| Race/ethnic and sex differences in large and small artery elasticity--results of the multi-ethnic study of atherosclerosis (MESA). | Q34076748 | ||
| Production of the long pentraxin PTX3 in advanced atherosclerotic plaques | Q34128059 | ||
| Pentraxin 3, a non-redundant soluble pattern recognition receptor involved in innate immunity | Q34199395 | ||
| Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction | Q34357988 | ||
| Associations of pentraxin 3 with cardiovascular disease and all-cause death: the Cardiovascular Health Study | Q37141153 | ||
| Relations of measures of endothelial function and kidney disease: the Framingham Heart Study | Q37150714 | ||
| The long pentraxin PTX3 is crucial for tissue inflammation after intestinal ischemia and reperfusion in mice | Q37164532 | ||
| Does racial variation in risk factors explain black-white differences in the incidence of hypertensive end-stage renal disease? | Q41189475 | ||
| Plasma pentraxin 3 in patients with chronic kidney disease: associations with renal function, protein-energy wasting, cardiovascular disease, and mortality | Q44571381 | ||
| Racial differences in the incidence of hypertensive end-stage renal disease (ESRD) are not entirely explained by differences in the prevalence of hypertension | Q44839105 | ||
| Endothelial dysfunction and oxidative stress in chronic renal failure. | Q45062452 | ||
| The long pentraxin PTX-3 in prevalent hemodialysis patients: associations with comorbidities and mortality. | Q53496784 | ||
| Distribution and correlates of arterial compliance measures in asymptomatic young adults: the Bogalusa Heart Study. | Q53857658 | ||
| Deficiency of the Long Pentraxin PTX3 Promotes Vascular Inflammation and Atherosclerosis | Q56942567 | ||
| Cardioprotective Function of the Long Pentraxin PTX3 in Acute Myocardial Infarction | Q56942653 | ||
| Arterial stiffness and enlargement in mild-to-moderate chronic kidney disease. | Q64985405 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | atherosclerosis | Q12252367 |
| multiethnicity | Q111242702 | ||
| P304 | page(s) | 1903-1908 | |
| P577 | publication date | 2010-11-15 | |
| P1433 | published in | Nephrology Dialysis Transplantation | Q15710302 |
| P1476 | title | Racial differences in the association of pentraxin-3 with kidney dysfunction: the Multi-Ethnic Study of Atherosclerosis | |
| P478 | volume | 26 |
| Q36533057 | Association between levels of pentraxin 3 and incidence of chronic kidney disease in the elderly |
| Q34150807 | Associations of pentraxin-3 with cardiovascular events, incident heart failure, and mortality among persons with coronary heart disease: data from the Heart and Soul Study |
| Q38084920 | Biology of human pentraxin 3 (PTX3) in acute and chronic kidney disease |
| Q40865321 | Correlation between arterial stiffness and inflammatory markers in autosomal dominant polycystic kidney disease patients with preserved renal function |
| Q38683930 | Early atherosclerosis in normotensive patients with autosomal dominant polycystic kidney disease: the relation between epicardial adipose tissue thickness and carotid intima-media thickness. |
| Q38087135 | Effects of hemodiafiltration on uremic inflammation |
| Q37370584 | Evaluation of the association of plasma pentraxin 3 levels with type 2 diabetes and diabetic nephropathy in a Malay population |
| Q37629231 | Interesting Correlation Between the Circulating Pentraxin 3 and Cardiac Rehabilitation Program Outcomes in Coronary Artery Bypass Grafting Patients |
| Q35576334 | Kidney function decline in the elderly: impact of lipoprotein-associated phospholipase A(2). |
| Q53648728 | Not all inflammatory markers are linked to kidney function: results from a population-based study. |
| Q33805985 | Pentraxin-3 and the right ventricle: the Multi-Ethnic Study of Atherosclerosis-Right Ventricle Study |
| Q48458509 | Pentraxin-3 in chronic heart failure: the CORONA and GISSI-HF trials |
| Q42777805 | RNA-seq analysis provide new insights into mapk signaling of apolipoproteinciii-induced inflammation in porcine vascular endothelial cells. |
| Q34736818 | Rosuvastatin preserves renal function and lowers cystatin C in HIV-infected subjects on antiretroviral therapy: the SATURN-HIV trial |
| Q55266003 | The association of angiogenic factors and chronic kidney disease. |
Search more.